ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · IEX Real-Time Price · USD
-0.050 (-1.10%)
Jun 18, 2024, 4:30 PM EDT - Market closed

ProPhase Labs Market Cap

ProPhase Labs has a market cap or net worth of $85.85 million as of June 18, 2024. Its market cap has decreased by -38.54% in one year.

Market Cap
Enterprise Value
1-Year Change
Stock Price

Market Cap Chart

Since December 1, 1998, ProPhase Labs's market cap has decreased from $92.00M to $85.85M, a decrease of -6.68%. That is a compound annual growth rate of -0.27%.


DateMarket Cap% Change
Jun 14, 202487.60M-1.24%
Jun 13, 202488.70M-2.53%
Jun 12, 202491.00M3.06%
Jun 11, 202488.30M2.79%
Jun 10, 202485.90M-2.94%
Jun 7, 202488.50M-3.38%
Jun 6, 202491.60M-1.19%
Jun 5, 202492.70M0.22%
Jun 4, 202492.50M-2.84%
Jun 3, 202495.20M-3.15%
May 31, 202498.30M4.35%
May 30, 202494.20M-4.17%
May 29, 202498.30M0.61%
May 28, 202497.70M1.45%
May 24, 202496.30M-5.31%
May 23, 2024101.70M3.35%
May 22, 202498.40M-1.01%
May 21, 202499.40M-0.60%
May 20, 2024100.00M4.17%
May 17, 202496.00M-1.54%
May 16, 202497.50M-0.61%
May 15, 202498.10M1.45%
May 14, 202496.70M-4.16%
May 13, 2024100.90M4.78%
May 10, 202496.30M8.45%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Asensus Surgical 89.91M
Clearside Biomedical 88.93M
Connect Biopharma Holdings 88.16M
Vivani Medical 87.97M
Verastem 87.88M
AlloVir 87.54M
PetMed Express 87.34M
Cognition Therapeutics 86.93M
Market Cap Rankings